Notice of Intent to Publish a Funding Opportunity Announcement for Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33, Clinical Trials Optional)

0
233

Opportunity ID: 310187
Opportunity Number: NOT-AT-19-006
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33, Clinical Trials Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s):
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Nov 05, 2018
Last Updated Date: Nov 05, 2018
Estimated Synopsis Post Date: Dec 08, 2018
Fiscal Year: 2019
Award Ceiling: $300,000
Award Floor:
Estimated Total Program Funding: $3,600,000
Expected Number of Awards: 8
Description: The National Center for Complementary and Integrative Health (NCCIH), along with partnering Institutes/Centers/Offices intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications to examine the impact of behavioral and social interventions designed to improve adherence to Medication Assisted Treatment (MAT) for persons with Opioid Use Disorders (OUD). Applications are encouraged for fully powered effectiveness and/or implementation studies that will examine whether combining MAT with behavioral and/or social interventions (e.g., mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation) can improve adherence to MAT and, at the same time, may prevent substance abuse relapse, and improve long-term abstinence from illicit opioids. Studies that address adherence determinants at more than one level of ecologic influence (including the patient, caregiver/family, providers and/or healthcare system, and community levels) are of higher priority. The FOA is expected to be published in the Fall of Fiscal Year (FY) 2019 with an expected application due date in the Winter of FY 2019 . This Notice encourages investigators with expertise and insights into behavioral and social interventions to improve medication assisted therapy (MAT) to begin to consider applying for this new FOA. This FOA will utilize the R01 activity code. Details of the planned FOA are provided below. This study is part of the of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative will bolster research across NIH to: (1) improve treatment for opioid misuse and addiction, and (2) enhance pain management. More information about the HEAL Initiative is available at: https://www.nih.gov/research-training/medical-research-initiatives/heal-initiative.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33, Clinical Trials Optional)